John Bannon Pharma are delighted to announce a new partnership with HA Derma, manufacturers of the Profhilo hyaluronic acid (HA) based product.
Profhilo is the first BDDE-free stabilised injectable HA based product for treating skin laxity.
With one of the highest concentrations of HA on the market (64mg / 2ml) it is not only boosting and hydrating the skin, but also remodels the ageing and sagging tissue.
Profhilo delivers great results as a treatment on its own or in combination with other aesthetics treatments currently on offer.
To avail of our special introductory offers on Profhilo please click here